Effect of Ergocalciferol on β-Cell Function in New-Onset Type 1 Diabetes A Secondary Analysis of a Randomized Clinical Trial

被引：0
|
作者：
Nwosu, Benjamin Udoka [1 ,2 ]
Parajuli, Sadichchha [2 ,3 ]
Sharma, Rohit B. [4 ]
Lee, Austin F. [5 ]
机构：
[1] Northwell Hlth, Cohen Childrens Med Ctr, Dept Pediat, Div Endocrinol, New Hyde Pk, NY USA
[2] Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA USA
[3] Louisiana State Univ Hosp, Monroe Family Med Program, Shreveport, LA USA
[4] Weill Cornell Med, Div Endocrinol Diabet & Metab, Dept Med, New York, NY USA
[5] Univ Massachusetts, Chan Med Sch, Dept Populat & Quantitat Hlth Sci, Worcester, MA 01605 USA
来源：
JAMA NETWORK OPEN | 2024年 / 7卷 / 03期
关键词：
D O I：
10.1001/jamanetworkopen.2024.1155
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This secondary analysis of a randomized clinical trial evaluates the effectiveness of ergocalciferol vs placebo in youths with newly diagnosed type 1 diabetes.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] The profile of blood microbiome in new-onset type 1 diabetes children
    Yuan, Xiaoxiao
    Yang, Xin
    Xu, Zhenran
    Li, Jie
    Sun, ChengJun
    Chen, Ruimin
    Wei, Haiyan
    Chen, Linqi
    Du, Hongwei
    Li, Guimei
    Yang, Yu
    Chen, Xiaojuan
    Cui, Lanwei
    Fu, Junfen
    Wu, Jin
    Chen, Zhihong
    Fang, Xin
    Su, Zhe
    Zhang, Miaoying
    Wu, Jing
    Chen, Xin
    Zhou, Jiawei
    Luo, Yue
    Zhang, Lei
    Wang, Ruirui
    Luo, Feihong
    ISCIENCE, 2024, 27 (07)
  • [42] Effect of intensive therapy on residual β-cell function in patients with type 1 diabetes in the diabetes control and complications trial -: A randomized, controlled trial
    不详
    ANNALS OF INTERNAL MEDICINE, 1998, 128 (07) : 517 - +
  • [43] Immunotherapy Related New-onset Type 1 Diabetes Mellitus and DKA
    Tun, M. T.
    Kaur, A.
    Santana, J. Cartagena
    Daniel, S.
    Ismail-Sayed, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [44] Severe hypertriglyceridemia with new-onset diabetes type 1 without ketoacidosis
    Bandura, M.
    Hennig, M.
    Mysliwiec, M.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 214 - 214
  • [45] New-Onset Type 1 Diabetes in Children and COVID-19
    Alexandre, Maria Ines
    Henriques, Ana Raquel
    Cavaco, Daniela
    Rodrigues, Luis
    Costa, Sara
    Robalo, Brigida
    Pereira, Carla
    Sampaio, Maria de Lurdes
    ACTA MEDICA PORTUGUESA, 2021, 34 (09): : 642 - 643
  • [46] Early CGM Initiation in New-Onset Type 1 Diabetes Patients
    Prahalad, Priya
    Scheinker, David
    Hood, Korey K.
    Buckingham, Bruce A.
    Wilson, Darrell M.
    Chmielewski, Annette
    Conrad, Barry P.
    Geels, Elena
    Leverenz, Jeannine
    Peterson, Kristine
    Maahs, David M.
    DIABETES, 2019, 68
  • [47] Antivirals Might Preserve Insulin in New-Onset Type 1 Diabetes
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (18): : 1724 - 1724
  • [48] Different reduction in residual β-cell function assessed from immunogenetic factors in patients with new-onset autoimmune type 1 diabetes
    Suzuki, Yoshifumi
    Hashimoto, Naotake
    Horie, Atsuya
    Sakurai, Kenichi
    Matsushima, Yasuhisa
    Yoshida, Syoji
    DIABETES, 2008, 57 : A413 - A413
  • [49] The potential effect of metabolic alkalosis on insulin sensitivity in an adolescent with new-onset type 1 diabetes
    Novotny, William E.
    Fiordalisi, Irma
    Keel, Cynthia P.
    Harris, Glenn D.
    CLINICAL CASE REPORTS, 2021, 9 (05):
  • [50] No Protective Effect of Calcitriol on β-Cell Function in Recent-Onset Type 1 Diabetes The IMDIAB XIII trial
    Bizzarri, Carla
    Pitocco, Dario
    Napoli, Nicola
    Di Stasio, Enrico
    Maggi, Daria
    Manfrini, Silvia
    Suraci, Concetta
    Cavallo, Maria Gisella
    Cappa, Marco
    Ghirlanda, Giovanni
    Pozzilli, Paolo
    DIABETES CARE, 2010, 33 (09) : 1962 - 1963
12345